Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Nat Genet. 2012 May 18;44(7):793-6. doi: 10.1038/ng.2324.
Cantú syndrome is characterized by congenital hypertrichosis, distinctive facial features, osteochondrodysplasia and cardiac defects. By using family-based exome sequencing, we identified a de novo mutation in ABCC9. Subsequently, we discovered novel dominant missense mutations in ABCC9 in 14 of the 16 individuals with Cantú syndrome examined. The ABCC9 protein is part of an ATP-dependent potassium (K(ATP)) channel that couples the metabolic state of a cell with its electrical activity. All mutations altered amino acids in or close to the transmembrane domains of ABCC9. Using electrophysiological measurements, we show that mutations in ABCC9 reduce the ATP-mediated potassium channel inhibition, resulting in channel opening. Moreover, similarities between the phenotype of individuals with Cantú syndrome and side effects from the K(ATP) channel agonist minoxidil indicate that the mutations in ABCC9 result in channel opening. Given the availability of ABCC9 antagonists, our findings may have direct implications for the treatment of individuals with Cantú syndrome.
坎图综合征的特征为先天性多毛症、特征性面部特征、骨软骨发育不良和心脏缺陷。通过基于家系的外显子组测序,我们在 1 名坎图综合征患者中发现 ABCC9 的新生突变。随后,在 16 名坎图综合征患者中发现了 ABCC9 的新型显性错义突变。ABCC9 蛋白是一种依赖于 ATP 的钾(K(ATP))通道的一部分,该通道将细胞的代谢状态与其电活性偶联。所有突变都改变了 ABCC9 的跨膜结构域中的或附近的氨基酸。通过电生理测量,我们表明 ABCC9 突变减少了 ATP 介导的钾通道抑制,导致通道开放。此外,坎图综合征患者的表型与 K(ATP)通道激动剂米诺地尔的副作用之间的相似性表明,ABCC9 突变导致通道开放。鉴于 ABCC9 拮抗剂的可用性,我们的发现可能对坎图综合征患者的治疗有直接影响。